Treponema-Specific Tests for Serodiagnosis of Syphilis: Comparative Evaluation of Seven Assays
- 1 April 2011
- journal article
- research article
- Published by American Society for Microbiology in Journal of Clinical Microbiology
- Vol. 49 (4), 1313-1317
- https://doi.org/10.1128/jcm.02555-10
Abstract
The diagnosis of syphilis is challenging and often relies on serologic tests to detect treponemal or nontreponemal antibodies. Recently, the Centers for Disease Control and Prevention and the Association of Public Health Laboratories proposed an update to the syphilis serology testing algorithm, in which serum samples are first tested using a treponema-specific test and positive samples are analyzed with a nontreponemal assay. The goal of this study was to compare the performance of seven treponemal assays (BioPlex 2200 syphilis IgG [Bio-Rad, Hercules, CA], fluorescent treponemal antibody [FTA] assay [Zeus Scientific, Raritan, NJ], Treponema pallidum particle agglutination [TP-PA; Fujirebio Diagnostics, Malvern, PA], Trep-Sure enzyme immunoassay [EIA; Phoenix Biotech, Oakville, Ontario, Canada], Trep-Chek EIA [Phoenix Biotech], Trep-ID EIA [Phoenix Biotech], and Treponema ViraBlot IgG [Viramed Biotech AG, Planegg, Germany]) using serum samples (n = 303) submitted to our reference laboratory. In addition to testing with these 7 assays, all samples were tested by a rapid plasma reagin (RPR) assay and a treponemal IgM Western blot assay (Viramed ViraBlot). Compared to the FTA assay as the gold standard, the evaluated treponemal tests demonstrated comparable levels of performance, with percent agreement ranging from 95.4% (95% confidence interval, 92.3 to 97.3) for the Trep-Sure EIA to 98.4% (96.1 to 99.4) for the Trep-ID EIA. Compared to a "consensus of the test panel" (defined as at least 4 of 7 treponemal tests being in agreement), the percent agreement ranged from 95.7% (92.7 to 97.5) for Trep-Sure to 99.3% (97.5 to 99.9) for Trep-ID. These data may assist clinical laboratories that are considering implementing a treponemal test for screening or confirmatory purposes.Keywords
This publication has 12 references indexed in Scilit:
- The Laboratory Impact of Changing Syphilis Screening From the Rapid-Plasma Reagin to a Treponemal Enzyme Immunoassay: A Case-study From the Greater Toronto AreaSexually Transmitted Diseases, 2011
- Serologic Testing for Syphilis in the United States: A Cost-Effectiveness Analysis of Two Screening AlgorithmsSexually Transmitted Diseases, 2011
- Development of a colloidal gold-immunochromatography assay to detect immunoglobulin G antibodies to Treponema pallidum with TPN17 and TPN47Diagnostic Microbiology and Infectious Disease, 2010
- Characterization of Treponema pallidum Particle Agglutination Assay-Negative Sera following Screening by Treponemal Total Antibody Enzyme ImmunoassaysClinical and Vaccine Immunology, 2010
- NovelTreponema pallidumSerologic Tests: A Paradigm Shift in Syphilis Screening for the 21st CenturyClinical Infectious Diseases, 2010
- Evaluation of the Bio-Rad BioPlex 2200 Syphilis Multiplex Flow Immunoassay for the Detection of IgM- and IgG-Class Antitreponemal AntibodiesClinical and Vaccine Immunology, 2010
- Evaluation of Two Immunoblot Assays and a Western Blot Assay for the Detection of Antisyphilis Immunoglobulin G AntibodiesClinical and Vaccine Immunology, 2010
- Syphilis testing algorithms using treponemal tests for initial screening--four laboratories, New York City, 2005-2006.2008
- Laboratory diagnosis and interpretation of tests for syphilis.1995
- The Measurement of Observer Agreement for Categorical DataBiometrics, 1977